DNA LATEST NEWS: SENIOR INVESTOR ADVISOR ROSEN Encourages Lossy Ginkgo Bioworks Holdings, Inc. Investors to Learn About Class Action Investigation
[ad_1] NEW YORK, October 7, 2021 / PRNewswire / – WHY: Rosen Law Firm, a global investor rights law firm, announces investigation of potential securities claims on behalf of shareholders of Ginkgo Bioworks Holdings, Inc. (NYSE: DNA) resulting from allegations that Ginkgo may have provided misleading marketing information to the investing public. SO WHAT: If … Read more